LMED Latamed Ai Corp.
Fundamentals / CIK 0001477960 / USDLatamed Ai Corp. reported $0 in revenue and a net loss of $316K for the trailing twelve months ended September 30, 2026.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LMED in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$0 Sep 30, 2026
-
Operating Income TTM-$275K Operating profit
-
Net Income TTM-$316K GAAP bottom line
-
Diluted EPS TTM-$0.00 Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026-- Total debt: --
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Total Operating Expenses | $172K | $3.30M | $829K |
| Operating Income | -$172K | -$3.30M | -$829K |
| Interest Expense | $36K | $37K | $30K |
| Income Before Tax | -$207K | -$3.26M | -$1.73M |
| Income Tax Expense | $0 | $0 | $0 |
| Net Income | -$207K | -$3.26M | -$1.73M |
| Diluted EPS | -- | -$0.11 | -$0.02 |
| Diluted Shares Outstanding | -- | 29.3M | 88.9M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $46K | $77K | $43K | $108K | $28K | $20K | $16K | $982K |
| Operating Income | -$46K | -$77K | -$43K | -$108K | -$28K | -$20K | -$16K | -$982K |
| Interest Expense | -$13K | $10K | $9.4K | $29K | $8.4K | $9.3K | $8.5K | $9.0K |
| Income Before Tax | -$58K | -$87K | -$53K | -$118K | -$36K | -$29K | -$24K | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$58K | -$87K | -$53K | -$118K | -$36K | -$29K | -$24K | -$917K |
| Basic EPS | -- | $0.00 | -- | -- | -- | $0.00 | -- | -- |
| Diluted EPS | $0.00 | -- | -- | -- | $0.00 | -- | -- | -- |
| Diluted Shares Outstanding | 180.7M | 46.7M | -- | -- | 146.4M | 29.3M | -- | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Total Current Assets | $0 | $0 | $0 |
| Intangible Assets | $0 | -- | -- |
| Total Non-Current Assets | $0 | $0 | $0 |
| Total Assets | $0 | $0 | $0 |
| Total Current Liabilities | $631K | $574K | $500K |
| Total Non-Current Liabilities | $0 | $0 | $0 |
| Total Liabilities | $631K | $574K | $500K |
| Common Stock | $22K | $29K | $257 |
| Retained Earnings | -$29.60M | -$29.39M | -$26.13M |
| Total Stockholders' Equity | -$631K | -$574K | -$500K |
| Total Equity | -$631K | -$574K | -$500K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $7.82M | -- | -- | $0 | -- | -- | -- | -- |
| Total Non-Current Assets | $7.82M | $7.82M | $7.82M | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $7.82M | $7.82M | $7.82M | $0 | $0 | $0 | $0 | $0 |
| Total Current Liabilities | $829K | $771K | $684K | $631K | $664K | $627K | $598K | $574K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $829K | $771K | $684K | $631K | $664K | $627K | $598K | $574K |
| Common Stock | $18K | $36K | $56K | $22K | $29K | $29K | $29K | $29K |
| Retained Earnings | -$29.80M | -$29.74M | -$29.65M | -$29.60M | -$29.48M | -$29.45M | -$29.42M | -$29.39M |
| Total Stockholders' Equity | $6.99M | $7.05M | $7.14M | -$631K | -$664K | -$627K | -$598K | -$574K |
| Total Equity | $6.99M | $7.05M | $7.14M | -$631K | -$664K | -$627K | -$598K | -$574K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | -$207K | -$3.26M | -$1.73M |
| Operating Cash Flow | -$206K | -$67K | -$70K |
| Common Stock Issued | $150K | -- | -- |
| Financing Cash Flow | $206K | $67K | $70K |
| Net Change in Cash | $0 | $0 | $0 |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$58K | -$87K | -$53K | -$118K | -$36K | -$29K | -$24K | -$917K |
| Operating Cash Flow | -$34K | -$55K | -$28K | -$158K | -$14K | -$15K | -$19K | -$9.6K |
| Financing Cash Flow | $34K | $55K | $28K | $158K | $14K | $15K | $19K | $9.6K |
| Net Change in Cash | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Current Ratio | 0.00x | 0.00x | 0.00x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -4.5% | -4.2% | -3.3% | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -4.0% | -3.8% | -3.0% | -- | -- | -- | -- | -- |
| Current Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |